Both in Surgical Instruments
Solventum vs DexCom
Over the past year SOLV returned +24.4% and DXCM returned +37.3%; their daily moves had a correlation of 0.24.
SOLV +24.4% DXCM +37.3%Growth of $1, one year, split-adjusted
| Metric | SOLV | DXCM |
|---|---|---|
| Price | $84.76 | $82.97 |
| Market cap | $14.43B | $30.94B |
| Today | +0.01% | −2.11% |
| 1 month | −3.7% | −4.5% |
| 6 months | +22.8% | +39.5% |
| Year to date | +7.0% | +25.0% |
| 1 year | +22.8% | +42.5% |
| Revenue growth (YoY) | +2.2% | +11.2% |
| Gross margin | 58.2% | 64.3% |
| Net margin | 4.2% | 20.5% |
| P/E (TTM) | 10.1× | 31.2× |
| Price / sales | 1.7× | 6.1× |
| Net cash | -$4.88B | $574.2M |
| Dividend yield | — | — |
| Volatility (60d) | 22.6% | 29.4% |
| Short % of float | 3.4% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).